- Home
- MPU vs PLRX Comparison
MPU vs PLRX Comparison
Compare MPU & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPU
- PLRX
- Stock Information
- Founded
- MPU 1989
- PLRX 2015
- Country
- MPU Singapore
- PLRX United States
- Employees
- MPU N/A
- PLRX N/A
- Industry
- MPU Transportation Services
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- MPU Consumer Discretionary
- PLRX Health Care
- Exchange
- MPU Nasdaq
- PLRX Nasdaq
- Market Cap
- MPU 88.9M
- PLRX 93.3M
- IPO Year
- MPU 1998
- PLRX 2020
- Fundamental
- Price
- MPU $1.20
- PLRX $1.82
- Analyst Decision
- MPU
- PLRX Hold
- Analyst Count
- MPU 0
- PLRX 11
- Target Price
- MPU N/A
- PLRX $3.93
- AVG Volume (30 Days)
- MPU 185.8K
- PLRX 966.5K
- Earning Date
- MPU 11-11-2025
- PLRX 11-07-2025
- Dividend Yield
- MPU N/A
- PLRX N/A
- EPS Growth
- MPU N/A
- PLRX N/A
- EPS
- MPU N/A
- PLRX N/A
- Revenue
- MPU $35,373,100.00
- PLRX N/A
- Revenue This Year
- MPU N/A
- PLRX N/A
- Revenue Next Year
- MPU N/A
- PLRX N/A
- P/E Ratio
- MPU N/A
- PLRX N/A
- Revenue Growth
- MPU 126.64
- PLRX N/A
- 52 Week Low
- MPU $0.49
- PLRX $1.10
- 52 Week High
- MPU $4.44
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- MPU 44.46
- PLRX 62.84
- Support Level
- MPU $1.06
- PLRX $1.45
- Resistance Level
- MPU $1.19
- PLRX $1.91
- Average True Range (ATR)
- MPU 0.10
- PLRX 0.11
- MACD
- MPU 0.04
- PLRX 0.04
- Stochastic Oscillator
- MPU 78.46
- PLRX 78.26
About MPU Mega Matrix Corp.
Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.